4.6 Review

From the Sea to Anticancer Therapy

期刊

CURRENT MEDICINAL CHEMISTRY
卷 18, 期 23, 页码 3551-3562

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986711796642652

关键词

Anti-cancer therapy; clinical trial; FDA-approval; EMEA-approval; marine compound; mechanism of action; pre-clinical trial; synthetic compound

向作者/读者索取更多资源

Discovery, isolation, characterisation and pre-clinical and clinical trials of plant-or animal-derived drugs displaying pharmacological activities continue to develop and enlarge. Cancer chemotherapy is one of the most promising areas for these drugs. Since a very long time, nature has been an attractive source of potential medicinal agents for human use. The deep sea is becoming a novel and potently appealing source for new drugs, as well as shallow waters. This interest is mainly related to the terrific chemical diversity found in the vast number of plants and animal species, as well as in the microbial world. During the evolution, a rich source of biologically active compounds is developed in the depths of the sea, often reflecting ecological adaptation. Most of them (toxins) are developed to allow survival and flourishing acting against predators and parasites. Recent progress in Scuba diving, hitech/biotechnological and procedural advances in structure clarification, organic synthesis and biological assay determined the characterisation and preclinical/clinical evaluation of novel anticancer drugs. The aim of this review is to provide a description of their discovery, mode of action and clinical application.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据